Effective tissue procurement and utilization is vital for meaningful translational research activities. TheTissue Procurement and Hematopathology Core will work with each SPORE project and the Biostatisticsand Data Management Core to ensure efficient and highly-coordinated procurement, use and storage ofblood and bone marrow samples. The Core will obtain and maintain a repository of blood samples (includingperipheral blood, bone marrow biopsies, and bone marrow aspirates) for laboratory use, with an effectivecoding system for all laboratory specimens to ensure patient confidentiality and prevent experimental bias.Continuous communication between the investigators, research nurses, biostatisticians andhematopathologists, as well as standardized operating procedures for activities will provide for optimal tissuecollection and accurate processing, analysis and storage of each sample. Thus, the functions of thePathology and Tissue Core are to facilitate acquisition, preservation, analysis and dispersal of clinicalsamples and to provide hematopathologic characterization and specimens for all project investigators.The Tissue Procurement and Hematopathology Core has the following objectives: Develop and maintain a repository of blood and bone marrow specimens, including intact cells,serum, cellular DNA, RNA and protein, from patients with leukemia and MDS (including patients whoare newly diagnosed, in remission and/or in relapse) receiving care or evaluation at M.D. AndersonCancer Center. Distribute tissue specimens to SPORE investigators for analysis and provideexpertise in the interpretation of studies performed on tissue sections within SPORE projects Providecomprehensive histologic characterization of blood and marrow samples used in SPORE projects,including specimens from patients entered onto clinical protocols. Provide stock and customized Reverse Phase Protein Arrays to Spore researchers. Maintain a comprehensive, prospective interactive database with detailed clinical and pathologic datafor patients with leukemia and MDS receiving care or evaluation at M.D. Anderson Cancer Center Facilitate inter-SPORE collaborations through sharing of blood and marrow resources.Lay Abstract: Effective tissue procurement and utilization is vital for meaningful translational researchactivities. The Tissue Procurement and Hematopathology Core will work with each SPORE project and theBiostatistics and Data Management Core to ensure efficient and highly-coordinated procurement, use andstorage of blood and bone marrow samples

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA100632-06
Application #
7468682
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (J1))
Project Start
2008-05-01
Project End
2013-04-30
Budget Start
2008-09-01
Budget End
2009-04-30
Support Year
6
Fiscal Year
2008
Total Cost
$171,859
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Kelly, Andrew D; Madzo, Jozef; Madireddi, Priyanka et al. (2018) Demethylator phenotypes in acute myeloid leukemia. Leukemia 32:2178-2188
Levis, Mark J; Perl, Alexander E; Altman, Jessica K et al. (2018) A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations. Blood Adv 2:825-831
Shah, Maitri Y; Ferracin, Manuela; Pileczki, Valentina et al. (2018) Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res 28:432-447
Masarova, Lucia; Verstovsek, Srdan; Hidalgo-Lopez, Juliana E et al. (2018) A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis. Blood 132:1664-1674
Good, Charly Ryan; Panjarian, Shoghag; Kelly, Andrew D et al. (2018) TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Res 78:4126-4137
Choi, Sangbum; Kang, Sangwook; Huang, Xuelin (2018) Smoothed quantile regression analysis of competing risks. Biom J 60:934-946
Boddu, Prajwal; Kantarjian, Hagop; Garcia-Manero, Guillermo et al. (2018) The emerging role of immune checkpoint based approaches in AML and MDS. Leuk Lymphoma 59:790-802
Yang, Tian-Hui; St John, Lisa S; Garber, Haven R et al. (2018) Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol 201:1389-1399
Rivera-Del Valle, Nilsa; Cheng, Tiewei; Irwin, Mary E et al. (2018) Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol 81:483-495
Le, Phuong M; Andreeff, Michael; Battula, Venkata Lokesh (2018) Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis. Haematologica :

Showing the most recent 10 out of 487 publications